Osaic Holdings’s Legend Biotech LEGN Stock Holding History

Osaic Holdings’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.9K	Buy	1,381 +142	+11%	+$3.83K	﹤0.01%	5639
2026 Q1	$22.4K	Buy	1,239 +1,227	+10,225%	+$23.4K	﹤0.01%	5779
2025 Q4	$260	Sell	12 -3	-20%	-$86	﹤0.01%	7544
2025 Q3	$532	Buy	+15	New	+$554	﹤0.01%	7532
2025 Q1	–	Sell	-10	Closed	-$325	–	7597
2024 Q4	$325	Buy	+10	New	+$414	﹤0.01%	7108
2023 Q3	–	Sell	-27	Closed	-$1.86K	–	7470
2023 Q2	$1.86K	Buy	27 +15	+125%	+$980	﹤0.01%	6692
2023 Q1	$579	Hold	12	–	–	﹤0.01%	7098
2022 Q4	$1K	Sell	12 -50	-81%	-$2.42K	﹤0.01%	6902
2022 Q3	$3K	Sell	62 -844	-93%	-$39.6K	﹤0.01%	6623
2022 Q2	$50K	Buy	+906	New	+$38.3K	﹤0.01%	4957

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Osaic Holdings's LEGN Position: Q2 2026 in Review

Osaic Holdings increased its Legend Biotech (LEGN) stake by 11% in Q2 2026, buying an estimated $3.83K and bringing the position to 1,381 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5639.

Osaic Holdings first reported a position in LEGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $50K in Q2 2022. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Osaic Holdings held 1,381 shares of Legend Biotech worth $39.9K as of Q2 2026.
Osaic Holdings bought 142 Legend Biotech shares in Q2 2026, an estimated $3.83K.
Legend Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5639 holding.
Osaic Holdings first reported a position in Legend Biotech in Q2 2022 and has held it in 10 quarters since.
Osaic Holdings's Legend Biotech position peaked at $50K in Q2 2022.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.